Research Articles | Page 16 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool. Jan 2012 Haematologica myelodysplastic syndromes (MDS)
Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki Oct 2016 Cancer Sci. myelodysplastic syndromes (MDS)
Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndromes Feb 2015 Eur J Haematol myelodysplastic syndromes (MDS)
Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience Sep 2020 Leukemia & Lymphoma acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience Aug 2017 Am J Hematol aplastic anemia
Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis May 2018 Clin Lymphoma Myeloma Leuk myelodysplastic syndromes (MDS)
Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes Jul 2012 Am J Med myelodysplastic syndromes (MDS)
Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussion. Nov 2012 Clin Adv Hematol Oncol paroxysmal nocturnal hemoglobinuria (PNH)
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry. May 2013 Int J Hematol myelodysplastic syndromes (MDS)